Fennec Pharmaceuticals Inc.

NasdaqCM:FENC Stock Report

Market Cap: US$173.3m

Fennec Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:FENC Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
01 Jul 24SellUS$14,902Rostislav RaykovIndividual2,431US$6.13
23 Apr 24BuyUS$51,335Adrian HaighIndividual22,223US$2.31
23 Apr 24SellUS$414,490Adrian HaighIndividual44,445US$9.34
15 Apr 24SellUS$8,360Chris RallisIndividual800US$10.45
26 Mar 24SellUS$23,191Chris RallisIndividual2,114US$10.97

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of FENC?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders485,8941.77%
Private Companies3,993,69414.6%
Institutions5,055,25818.4%
General Public7,962,54729%
Hedge Funds9,930,31136.2%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 68.77% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
14.9%
Southpoint Capital Advisors LP
4,077,214US$25.8m0%0.58%
14.6%
Alfasigma S.p.A.
3,993,694US$25.2m0%no data
8.78%
Sonic GP LLC
2,407,357US$15.2m0%29.08%
7.01%
Solas Capital Management, LLC
1,923,536US$12.2m43.6%5.93%
5.55%
DG Capital Management, LLC
1,522,204US$9.6m-6.89%5.26%
4.48%
BlackRock, Inc.
1,229,477US$7.8m3.56%no data
3.82%
The Vanguard Group, Inc.
1,047,891US$6.6m2.07%no data
1.7%
Harbert Fund Advisors, Inc.
466,869US$3.0m0%2.25%
1.2%
State Street Global Advisors, Inc.
328,259US$2.1m2.2%no data
1.09%
Geode Capital Management, LLC
299,298US$1.9m-0.76%no data
0.85%
Tontine Management, LLC
231,841US$1.5m-18.2%0.05%
0.78%
Lion Point Capital, LP
215,000US$1.4m26.5%5.42%
0.78%
Khalid Islam
213,825US$1.4m0%no data
0.51%
Northern Trust Global Investments
139,731US$883.1k31.3%no data
0.47%
Robert Andrade
128,423US$811.6k16.2%no data
0.33%
Rostislav Raykov
91,432US$577.9k37.6%no data
0.32%
Morgan Stanley, Investment Banking and Brokerage Investments
86,683US$547.8k78.8%no data
0.26%
Winton Capital Group Limited
71,656US$452.9k6.94%0.03%
0.23%
Eaton Vance Management
61,779US$390.4k15.6%no data
0.22%
Russell Investment Management, LLC
59,817US$378.0k12.2%no data
0.2%
Charles Schwab Investment Management, Inc.
55,452US$350.5k0%no data
0.2%
Goldman Sachs Group, Investment Banking and Securities Investments
53,753US$339.7k167%no data
0.19%
Advantage Alpha Capital Partners LP
52,876US$334.2k0%0.07%
0.19%
Chris Rallis
52,214US$330.0k4.64%no data
0.19%
BNY Asset Management
51,723US$326.9k-24.7%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 03:13
End of Day Share Price 2025/01/02 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Fennec Pharmaceuticals Inc. is covered by 8 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Naureen QuibriaCapital One Securities, Inc.
Robin Garner KalleyCraig-Hallum Capital Group LLC
Chase KnickerbockerCraig-Hallum Capital Group LLC